Assyro AI

Orange Book product · Generic (ANDA)

METHYLPHENIDATE HYDROCHLORIDE

METHYLPHENIDATE HYDROCHLORIDE

Generic (ANDA)ANDA 211796TE AB1RX GRANULES

At a glance

May 23, 2019

Approved

Generic (ANDA)

Application

AB1

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 23, 2019

    7 yr 2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

METHYLPHENIDATE HYDROCHLORIDE

Strength

60MG

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

TE code

AB1

Application

ANDA 211796

Product number

005

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Active-ingredient family

View full family

Generic (ANDA) of METHYLPHENIDATE HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.